Institut De Cancérologie De Lorraine
Clinical trials sponsored by Institut De Cancérologie De Lorraine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may predict cancer recurrence in head and neck patients Results expected Sep 2026 (estimated)
- Study tests if lowering beeping alarms eases brain strain for trainee surgeons Results expected Jan 2027 (estimated)
- Hypnosis app aims to tame hot flashes for breast cancer patients Results expected Apr 2027 (estimated)
- Could less radiation be just as good for bone cancer pain? Results expected Jul 2027 (estimated)
- Hearing aids tested to ease chemotherapy side effect Results expected Sep 2027 (estimated)
-
Can talking to a nurse protect your brain during chemo?
Symptom relief OngoingThis study tests whether a personalized support program led by a nurse can help prevent memory and thinking problems that often occur after chemotherapy in women with non-metastatic breast cancer. Fifty women will receive regular face-to-face and telephone interviews over 9 month…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Blood test could predict melanoma treatment failure
Knowledge-focused OngoingThis study looks at whether analyzing tumor DNA in the blood can help monitor melanoma after surgery. Researchers will collect blood samples from 136 patients before and after surgery, and every 3-4 months, to see if changes in DNA levels predict when a treatment stops working. T…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Study tests if lowering beeping alarms eases brain strain for trainee surgeons
Knowledge-focused OngoingThis study looks at whether turning down the volume of anesthesia alarms can help surgical trainees think more clearly during practice surgeries. About 26 surgeons-in-training will perform simulated procedures with either standard or quieter alarms. Researchers will measure menta…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Blood test may replace tissue biopsies for ovarian cancer monitoring
Knowledge-focused OngoingThis study looks at whether a simple blood test (liquid biopsy) can track how ovarian cancer changes over time, instead of taking multiple tissue samples. Twenty newly diagnosed patients will give blood and tissue samples during their treatment for up to two years. The goal is to…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:28 UTC